Team:SJTU-BioX-Shanghai/Project/CRISPRi/Why

From 2013.igem.org

Stay on Targets


Recently, it has been reported that CRISPR/Cas exhibits noticible off-target effects (Fu et al., 2013). Although it is still under exploration and debate, the topic has no wonder raised concern of all those biologists who wish to utilize CRISPR in their research.

And for us, though we are still convinced that CRISPRi is a best choice for sequence-specific projects. It is true that, with each ribonucleotide in the gRNA as a recognizing module, recognizing one deoxyribonucleotide of the target, the accuracy of CRISPR may not be as good as Transcription Activtor-like effectors (TALEs), in which each peptide segment recognizes one pair of deoxyribonucleotides. However, the modularity of ribonucleotides are much better than peptides. Therefore, to target a 20bp DNA, we still prefer CRISPRi.

Despite all these comparison, we still take all measures to reduce potential "off-targets"(Carroll, 2013), ever from the beginning of our project. For each gRNA we design, we will check its potential mismatches, BLASTing them against the genome of Escherichia coli BL21(DE3).

We would like to share the gRNA sequence used in our project (only the base-pairing region is shown here): GRNA list.png

To get rid of the labor of manually BLASTing, we wrote a simple Python script to help us with the work. By far the programe is only able to conduct BLAST against a local database of E. coli genome. But we plan to offer a public WEB CGI (Common Gateway Interface) that can search NCBI directly in the future.

References


FU, Y., FODEN, J. A., KHAYTER, C., MAEDER, M. L., REYON, D., JOUNG, J. K. & SANDER, J. D. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature Biotechnology, 31, 822-826.

CARROLL, D. 2013. Staying on target with CRISPR-Cas. Nature Biotechnology, 31, 807-809.